Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime
Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Francesco Fanfani(Agostino Gemelli University Polyclinic), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Virginia Vargiu(Agostino Gemelli University Polyclinic), Alessandra De Finis(University of Parma), Giulio Sozzi(University of Palermo), Giuseppe Barresi(University of Parma), Giuseppe Maglietta(University of Parma), Francesco Cosentino, Andrea Rosati(Agostino Gemelli University Polyclinic), Luciano Monfardini(University of Parma), Giorgio Bogani(Fondazione IRCCS Istituto Nazionale dei Tumori), Tullio Ghi(University of Parma), Marco Carnelli(Ospedale Papa Giovanni XXIII)
Cited by 6
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299